Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Biosens Bioelectron ; 261: 116495, 2024 Oct 01.
Article in English | MEDLINE | ID: mdl-38878699

ABSTRACT

In this study, we have for the first time constructed a ratiometric ECL biosensor for the ultrasensitive detection of microRNAs (miRNAs) using gold nanoparticles (Au NPs) to trigger both the low-potential emission from conjugated polymer poly(9,9-dioctylfluorene-2,7-diyl) dots (PFO Pdots) and the LSPR-ECL effect with sulfur-doped boron nitride quantum dots (S-BN QDs). PFO Pdots were first applied to the Au NPs-modified electrode, followed by covalent binding to capture the hairpin H1. Immediately thereafter, a small amount of miRNA-141 was able to generate a large amount of output DNA (OP) by traversing the target cycle. OP, H3-S-BN QDs, and H4-glucose oxidase (H4-GOD) were then added sequentially to the Au NPs-modified electrode surface, and the hybridization chain reaction (HCR) was initiated. This resulted in the introduction of a large amount of GOD into the system, which catalyzed the in situ formation of the co-reactant hydrogen peroxide (H2O2) from the substrate glucose. Due to the electron transfer effect, the production of H2O2 led to the ECL quenching of PFO Pdots. Meanwhile, H2O2 served as a co-reactant of S-BN QDs, resulting in strong ECL emission of S-BN QDs at the cathode. Furthermore, the cathodic ECL intensity of S-BN QDs was further enhanced by an LSPR-ECL mechanism between Au NPs and S-BN QDs. By measuring the ratio of ECL intensities at two excitation potentials, this approach could provide sensitive and reliable detection of miRNA-141 in the range of 0.1 fM ∼10 nM, with a detection limit of 0.1 fM.


Subject(s)
Biosensing Techniques , Electrochemical Techniques , Gold , Limit of Detection , Luminescent Measurements , Metal Nanoparticles , MicroRNAs , Quantum Dots , Biosensing Techniques/methods , Gold/chemistry , MicroRNAs/analysis , Metal Nanoparticles/chemistry , Quantum Dots/chemistry , Electrochemical Techniques/methods , Humans , Luminescent Measurements/methods , Fluorenes/chemistry , Glucose Oxidase/chemistry , Hydrogen Peroxide/chemistry
2.
Anal Chem ; 96(15): 5852-5859, 2024 Apr 16.
Article in English | MEDLINE | ID: mdl-38556977

ABSTRACT

A multicolor electrochemiluminescence (ECL) biosensor based on a closed bipolar electrode (BPE) array was proposed for the rapid and intuitive analysis of three prostate cancer staging indicators. First, [Irpic-OMe], [Ir(ppy)2(acac)], and [Ru(bpy)3]2+ were applied as blue, green, and red ECL emitters, respectively, whose mixed ECL emission colors covered the whole visible region by varying the applied voltages. Afterward, we designed a simple Mg2+-dependent DNAzyme (MNAzyme)-driven tripedal DNA walker (TD walker) to release three output DNAs. Immediately after, three output DNAs were added to the cathodic reservoirs of the BPE for incubation. After that, we found that the emission colors from the anode of the BPE changed as a driving voltage of 8.0 V was applied, mainly due to changes in the interfacial potential and faradaic currents at the two poles of the BPE. Via optimization of the experimental parameters, cutoff values of such three indicators at different clinical stages could be identified instantly with the naked eye, and standard precision swatches with multiple indicators could be prepared. Finally, in order to precisely determine the prostate cancer stage, the multicolor ECL device was used for clinical analysis, and the resulting images were then compared with standard swatches, laying the way for accurate prostate cancer therapy.


Subject(s)
Biosensing Techniques , Prostatic Neoplasms , Male , Humans , Luminescent Measurements/methods , Photometry , Prostatic Neoplasms/diagnosis , Prostate-Specific Antigen , DNA , Biosensing Techniques/methods , Electrodes , Electrochemical Techniques/methods
3.
Ying Yong Sheng Tai Xue Bao ; 32(3): 951-958, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33754561

ABSTRACT

To solve the problem of uncoordinated source-sink relationship that limits the increase of peanut yield, we investigated the regulating effects of ethephon on the formation of source-sink in cultivar Shanhua 9 by spraying at 10, 20, and 30 d after anthesis in a field experiment. The results showed that spraying ethephon at 10 d and 20 d after anthesis significantly reduced the number of flowers, pegs and young pods, but increased the number of immature pods and mature pods. Spraying at 30 d after anthesis did not affect the number of flowers, pegs and young pods. Spraying ethephon could improve the leaf area per plant. Spraying at 10 d after anthesis achieved the highest leaf area per plant and the increment amplitude decreased with the delay of spraying stage. Spraying ethephon at 10 d and 20 d after anthesis significantly improved the photosynthetic performance of peanut, whereas spraying at 30 days after anthesis increased the photosynthesis only in the short-term and had no effect at late growth period. In terms of the comprehensive characters of source and sink, spraying ethephon at 20 d after anthesis achieved the most harmonious source-sink relationship, which could promote the transport of photosynthate to pods and increase the economic pods ratio, pod fullness, and the yield. Therefore, spraying ethephon is an effective practice to solve the problems of "more flowers but less pegs" and "more pods but less kernels" in peanut. The optimum spraying stage of ethephon to regulate flowering should be at 20 d after anthesis.


Subject(s)
Arachis , Photosynthesis , Organophosphorus Compounds/pharmacology , Plant Leaves
4.
Cell Biochem Biophys ; 62(1): 87-90, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22006254

ABSTRACT

To explore the effects of atorvastatin on hydrocephalus, neurocyte apoptosis, and the level of plasma matrix metalloproteinase-9 (MMP-9) after intracerebral hemorrhage (ICH) in rats. A rat model of ICH was established by intracerebral injection of collagenase. The brain water content was determined by the wet/dry weight ratio, ultrastructural changes in brain tissue were observed by electron microscopy, and the level of plasma MMP-9 was quantified by ELISA. Atorvastatin showed significant effects in reducing the brain water content, blocking neuron apoptosis, and decreasing plasma MMP-9 in rats with ICH. There was a positive linear correlation between plasma MMP-9 and the brain water content. Atorvastatin can significantly relieve brain edema, decrease the brain injury caused by MMP-9 and protect neurons in rats with ICH.


Subject(s)
Brain/drug effects , Brain/pathology , Cerebral Hemorrhage/metabolism , Heptanoic Acids/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Matrix Metalloproteinase 9/blood , Neuroprotective Agents/pharmacology , Pyrroles/pharmacology , Animals , Atorvastatin , Brain Edema/drug therapy , Brain Edema/metabolism , Brain Edema/pathology , Cerebral Hemorrhage/drug therapy , Disease Models, Animal , Heptanoic Acids/therapeutic use , Male , Neuroprotective Agents/therapeutic use , Pyrroles/therapeutic use , Rats , Rats, Wistar , Water/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...